Monday, July 1, 2013

Rainbow Coral Corp. (RBCC) Partner Successfully Raises Funds for New Drug Delivery Solutions

Today before the opening bell, Rainbow Coral applauded the fundraising results achieved by joint venture partner TheraKine, Ltd.

“TheraKine has done a tremendous job of bringing in outside funds to help push its innovations further into a hungry marketplace,” said RBCC CEO Patrick Brown. “The interest in TheraKine’s new drug delivery solutions is a fantastic illustration of this new system’s incredible market potential.”

Rainbow Coral signed a joint venture agreement with TheraKine earlier this year to help market and develop a revolutionary, sustained-release drug delivery platform designed to make local delivery of biologic agents and small molecules safer, more effective, and more convenient. TheraKine’s novel, patented technologies have the potential to enable selective, site-specific drug delivery, allowing for lower drug concentrations and significantly reducing the risk of drug toxicity.

As TheraKine concentrates on outside fundraising in order to market these technologies around the globe, RBCC is seeking out interested healthcare providers with clients that would highly value TheraKine’s advanced sustained-release delivery system.

The global market for drug delivery technologies is driven by biologics and medications that can’t be administered effectively through traditional means. Some experts believe that the worldwide market for the 10 most popular drug delivery technologies alone could grow to $81.5 billion by 2015.

RBCC is dedicated to delivering new medical research and technologies. For more information on RBCC’s initiatives, please visit www.rainbowbiosciences.com/investors.html.

About QualityStocks


QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: